Basilea beginnt Phase-1/2-Studie FIDES-03 mit Derazantinib bei Patienten mit Magenkrebs

NEXT STORY
GENFIT and LabCorp Sign Exclusive Agreement to Commercialize a Novel Diagnostic Test for Liver Disease
PREV STORY
Kiadis and Gulf Coast Regional Blood Center announce collaboration to provide universal donor material for K-NK cell therapy programs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Corcept Therapeutics Announces First Quarter 2020 Financial Results And Provides Corporate Update

author_avatar
NASDAQ Market News

Vir Biotechnology to Host a Call on Sotrovimab’s Retained Activity Against the Omicron SARS-CoV-2 Variant

author_avatar
NASDAQ Market News

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in electroCore, Inc. of Class Action Lawsuit and Upcoming Deadline – ECOR

author_avatar
NASDAQ Market News